18 July 2025 in Science Advances
The rise in global antibiotic resistance highlights the urgent need for effective antimicrobial agents. Antimicrobial peptides (AMPs) offer a potential solution to combat bacterial resistance. However, key challenges remain in addressing the limitations of current peptide drugs and biomaterials, such as narrow action modes, poor protease stability, and challenges in pathogen-specific targeting. This study introduces a series of multifunctional AMPs by integrating self-assembling systems. By regulating the length of cationic amino acid side chains, the optimized peptide Nhar was identified as a triple-functional candidate with the potential to solve these limitations. In aqueous solutions, Nhar self-assembles into nanofibers that trap pathogens, prevent their spread, and selectively kill Gram-positive bacteria. Nhar demonstrates remarkable protease resistance, retaining antimicrobial activity even under protease conditions (10 milligrams per milliliter). It induces bacterial death primarily through membrane disruption and multiple synergistic mechanisms. In a Staphylococcus aureus –induced mouse bacteremia model, Nhar showed promising therapeutic potential. This work offers important insights for developing multifunctional antimicrobial therapies.
2 November 2025 in Aggregate
Natural antimicrobial peptides (AMPs) encounter significant challenges in transitioning to clinical application, primarily due to low bioactivity, high toxicity, and poor stability. This study proposes a strategy to enhance the stability of AMPs through molecular assembly while exploring the advantages of the newly designed self‐assembled peptides compared to unimer peptides. We conducted a comprehensive investigation of antimicrobial activity, biocompatibility, in vitro stability, and particularly protease stability, aiming to develop highly efficient and stable designer peptides as alternatives to traditional antibiotics. A series of designer peptides with self‐assembling capabilities was constructed by attaching various hydrophobic scaffolds to an enzyme‐resistant short peptide sequence. The self‐assembled designer peptide Pba* with 1‐pyrenebutyric acid (Pba) as the hydrophobic scaffold exhibited the highest antibacterial activity (GM MIC = 2.88) and the greatest clinical potential (GM SI = 44.44), while maintaining excellent biocompatibility and physiological stability. Mechanistic studies revealed that Pba* self‐assembled into spherical micelles and nanofibers, trapping bacteria and disrupting cell membranes, interfering with respiration and energy metabolism. Notably, Pba* displayed negligible toxicity and alleviated bacterial infections in mice. This study paves the way for the development of highly effective antimicrobial materials.